These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38644691)

  • 1. Comprehensive Analysis of N6-Methylandenosine-Related lncRNAs in Clear Cell Renal Cell Carcinoma: A Correlation With Prognosis, Tumor Progression, and Therapeutic Response.
    Meng C; Li J; Wang X; Ying Y; Li Z; Wang A; Li X
    Cancer Invest; 2024 Apr; 42(4):278-296. PubMed ID: 38644691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics analysis and experimental validation of cuproptosis-related lncRNA LINC02154 in clear cell renal cell carcinoma.
    Shen J; Wang L; Bi J
    BMC Cancer; 2023 Feb; 23(1):160. PubMed ID: 36797708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis on the N6-methyladenosine-related long noncoding RNAs prognostic signature, immune checkpoints, and immune cell infiltration in clear cell renal cell carcinoma.
    Qiu Y; Wang X; Fan Z; Zhan S; Jiang X; Huang J
    Immun Inflamm Dis; 2021 Dec; 9(4):1596-1612. PubMed ID: 34432955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
    Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
    Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subtypes of clear cell renal carcinoma based on PCD-related long non-coding RNAs expression: insights into the underlying mechanisms and therapeutic strategies.
    Wang H; Liu Y; Tang A; Zhang X
    Eur J Med Res; 2024 May; 29(1):292. PubMed ID: 38773560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased expression of a novel lncRNA CADM1-AS1 is associated with poor prognosis in patients with clear cell renal cell carcinomas.
    Yao J; Chen Y; Wang Y; Liu S; Yuan X; Pan F; Geng P
    Int J Clin Exp Pathol; 2014; 7(6):2758-67. PubMed ID: 25031695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
    Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
    Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma.
    Zhou L; Fang H; Guo F; Yin M; Long H; Weng G
    J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel disulfidptosis-related lncRNA signature for prognostic and immune response prediction in clear cell renal cell carcinoma.
    Wang N; Hu Y; Wang S; Xu Q; Jiao X; Wang Y; Yan L; Cao H; Shao F
    Sci Rep; 2024 Jan; 14(1):624. PubMed ID: 38182642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
    Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C
    Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
    Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
    Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immune-related lncRNA risk coefficient model to predict the outcomes in clear cell renal cell carcinoma.
    Tang C; Qu G; Xu Y; Yang G; Wang J; Xiang M
    Aging (Albany NY); 2021 Dec; 13(24):26046-26062. PubMed ID: 34954690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma.
    Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X
    Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Liu Q; Lei C
    Ann Med; 2021 Dec; 53(1):2153-2164. PubMed ID: 34783622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A regulatory circuit of lncRNA NLGN1-AS1 and Wnt signalling controls clear cell renal cell carcinoma phenotypes through FZD4-modulated pathways.
    Gao H; Chen W; Pan G; Liu H; Qian J; Tang W; Wang W; Qian S
    Aging (Albany NY); 2022 Sep; 15(24):15624-15639. PubMed ID: 36170021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.
    Zhang C; Huang D; Liu A; Xu Y; Na R; Xu D
    J Cell Biochem; 2020 Mar; 121(3):2559-2570. PubMed ID: 31646670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of m6A-associated ferroptosis genes in renal clear cell carcinoma.
    Pang S; Zhao S; Dongye Y; Fan Y; Liu J
    Cell Biol Int; 2024 Jun; 48(6):777-794. PubMed ID: 38440906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of N6-Methyladenosine-Related IncRNAs Prognostic Signature and the Associated Immune Infiltrates in Kidney Renal Clear Cell Carcinoma.
    Chen X; Wang L; Tu J; Pan X; Li Y; Yin H; Wang M; Yuan X
    Crit Rev Eukaryot Gene Expr; 2022; 32(1):79-98. PubMed ID: 35377983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.